Media report: New hope for prostate cancer - through diabetes drug

Press coverage of the latest publication on new insights into metastatic prostate cancer, cancer metabolism and novel therapeutic concepts with diabetes drugs published in Molecular Cancer (impact factor 37.2). Derstandard.at reports in detail about the recent publication of Lukas Kenner's group in cooperation with the University of Cambridge and Fritz Aberger's laboratory from the Cancer Cluster Salzburg and the Department of Biosciences and Medical Biology at the University of Salzburg.

Full paper at BMC Molecular Cancer